M Minamitani

915 total citations · 1 hit paper
28 papers, 691 citations indexed

About

M Minamitani is a scholar working on Epidemiology, Pharmacology and Immunology. According to data from OpenAlex, M Minamitani has authored 28 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 5 papers in Pharmacology and 5 papers in Immunology. Recurrent topics in M Minamitani's work include Herpesvirus Infections and Treatments (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Virology and Viral Diseases (4 papers). M Minamitani is often cited by papers focused on Herpesvirus Infections and Treatments (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Virology and Viral Diseases (4 papers). M Minamitani collaborates with scholars based in Japan and United States. M Minamitani's co-authors include Vincent A. Fulginiti, Otto F. Sieber, Gordon Meiklejohn, Jerry J. Eller, Naohide Takayama, Michiko Takayama, C. Henry Kempe, Henry R. Shinefield, Kohei Miyazono and Tatsutoshi Nakahata and has published in prestigious journals such as PEDIATRICS, American Journal of Epidemiology and AIDS.

In The Last Decade

M Minamitani

24 papers receiving 628 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RESPIRATORY VIRUS IMMUNIZATION

1969 476 citations Vincent A. Fulginiti, M Minamitani et al. profile →

Peers

M Minamitani

EPIDE

ID

PRM

IMMUN

GENET

Benita Zweygberg Wirgart Sweden

Wieslawa Olszewska United Kingdom

Alfred D. Heggie United States

FRANCIS M. MASTROTA United States

Nahmias Aj United States

Heidi Smuts South Africa

J. H. Schieble United States

Mary Rinki United States

M Midulla Italy

Benita Zweygberg Wirgart Sweden

M Minamitani

544 ×0.9

EPIDE

259 ×0.9

ID

109 ×0.6

PRM

95 ×1.0

IMMUN

47 ×0.6

GENET

Citations per year, relative to M Minamitani M Minamitani (= 1×) peers Benita Zweygberg Wirgart

Countries citing papers authored by M Minamitani

Since Specialization

Citations

This map shows the geographic impact of M Minamitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Minamitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Minamitani more than expected).

Fields of papers citing papers by M Minamitani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Minamitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Minamitani. The network helps show where M Minamitani may publish in the future.

Co-authorship network of co-authors of M Minamitani

This figure shows the co-authorship network connecting the top 25 collaborators of M Minamitani. A scholar is included among the top collaborators of M Minamitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Minamitani. M Minamitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hara, Takashi, Naoto Yoshino, Naohide Takayama, et al.. (2001). Presence of Multiple HIV Type 1 Subtypes among Mothers and Children in Japan. AIDS Research and Human Retroviruses. 17(6). 569–575. 3 indexed citations

2.

Takayama, Naohide, M Minamitani, & Michiko Takayama. (1997). High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain). Pediatrics International. 39(6). 663–668. 31 indexed citations

3.

Takayama, Naohide, et al.. (1997). Varicella in Adulthood: Clinical Features, Severity Scores, Source of Infection and Complications. Kansenshogaku zasshi. 71(11). 1113–1119. 3 indexed citations

4.

Takayama, Naoya & M Minamitani. (1990). Mild Varicella observed in Children vaccinated with Varicella Vaccine between 1984 and 1987. Kansenshogaku zasshi. 64(2). 188–194. 2 indexed citations

5.

Kimura, Satoshi, Juzo Matsuda, Kohei Miyazono, et al.. (1990). Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. AIDS. 4(12). 1251–1256. 46 indexed citations

6.

Takayama, Michiko, et al.. (1989). Comparative restriction endonuclease analysis of varicella-zoster virus clinical isolates. Medical Microbiology and Immunology. 178(2). 61–7. 4 indexed citations

7.

Takayama, Naoya, et al.. (1989). Seroepidemiology of pertussis in the Japanese population. Medical Microbiology and Immunology. 178(1). 1–8. 15 indexed citations

8.

Minamitani, M, et al.. (1989). [A clinical evaluation of cefpodoxime proxetil in pediatrics].. PubMed. 42(7). 1488–97. 1 indexed citations

9.

Takayama, Naohide, et al.. (1988). Seroepidemiology of Tetanus and Diphtheria in the Japanese Population. Kansenshogaku zasshi. 62(7). 657–663. 1 indexed citations

10.

Minamitani, M, et al.. (1984). [Clinical study on ceftazidime in the field of pediatrics].. PubMed. 37(3). 377–88. 1 indexed citations

11.

Minamitani, M, et al.. (1981). [Clinical studies of cefotiam in the field of pediatrics (author's transl)].. PubMed. 34(5). 663–9. 1 indexed citations

12.

Minamitani, M, et al.. (1977). [Clinical study of S-6437 in pediatrics (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(9). 677–83. 1 indexed citations

13.

Kempe, C. Henry, Vincent A. Fulginiti, M Minamitani, & Henry R. Shinefield. (1968). SMALLPOX VACCINATION OF ECZEMA PATIENTS WITH A STRAIN OF ATTENUATED LIVE VACCINIA (CVI-78). PEDIATRICS. 42(6). 980–985. 38 indexed citations

14.

Minamitani, M, et al.. (1968). [Virus infections with exanthema].. PubMed. 23(6). 1146–55. 1 indexed citations

15.

Minamitani, M. (1968). Disc plate assay of vaccinia antibodies. Archives of Virology. 23(3). 194–201. 2 indexed citations

16.

Minamitani, M, et al.. (1964). Vaccination by Respiratory Route with Live Attenuated Measles Virus, Sugiyama, adapted to Bovine Renal Cells.. 34(2). 2 indexed citations

17.

Minamitani, M, et al.. (1964). VACCINATION BY RESPIRATORY ROUTE WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE REA RESPIRATORY ROUTE WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.. PubMed. 34. 81–4. 2 indexed citations

18.

Minamitani, M, et al.. (1963). SEROLOGICAL STUDY OF A MEASLES OUTBREAK IN AN INSTITUTION, TOKYO, 1962.. PubMed. 33. 121–31. 1 indexed citations

19.

Mutai, Masahiko, et al.. (1962). Live measles-virus vaccine: clinical trial of vaccine prepared from a variant of the Sugiyama strain adapted to bovine kidney cells.. PubMed. 32. 433–48. 13 indexed citations

20.

Yoshino, Kamesaburo, et al.. (1962). A SEROLOGICAL SURVEY FOR ANTIBODIES AGAINST HERPES SIMPLEX VIRUS WITH SPECIAL REFERENCE TO COMPARATIVELY HEAT-LABILE COMPLEMENT-FIXING ANTIBODIES. Japanese Journal of Medical Science and Biology. 15(5-6). 235–247. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact